URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Asbury

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Agents
24
1982
619
2.900
Why?
Imides
6
1993
7
1.750
Why?
Isoquinolines
6
1993
61
1.720
Why?
Thiadiazoles
7
1986
12
1.360
Why?
Uterine Neoplasms
5
1990
105
1.250
Why?
Antineoplastic Combined Chemotherapy Protocols
13
1985
429
0.850
Why?
Carcinoma
5
1989
191
0.820
Why?
Uterine Cervical Neoplasms
4
1987
125
0.810
Why?
Endometrial Neoplasms
3
1996
37
0.810
Why?
Colonic Neoplasms
6
1985
124
0.730
Why?
Carcinoma, Squamous Cell
4
1987
236
0.660
Why?
Neoplasm Recurrence, Local
5
1989
288
0.650
Why?
Lung Neoplasms
10
1983
439
0.640
Why?
Mixed Tumor, Mesodermal
2
1996
2
0.610
Why?
Leiomyosarcoma
2
1995
18
0.580
Why?
Adenocarcinoma
8
1985
439
0.510
Why?
Paclitaxel
5
1995
58
0.500
Why?
Carcinoma, Non-Small-Cell Lung
5
1994
72
0.490
Why?
Middle Aged
34
1980
9837
0.480
Why?
Etoposide
9
1983
83
0.450
Why?
Aged
28
1984
7269
0.450
Why?
Ovarian Neoplasms
4
1984
106
0.440
Why?
Goserelin
1
2002
7
0.440
Why?
Naphthalimides
6
1993
9
0.440
Why?
Antineoplastic Agents, Hormonal
1
2002
46
0.420
Why?
Female
40
1981
19838
0.410
Why?
Topotecan
1
2000
4
0.360
Why?
Humans
46
1980
36274
0.330
Why?
Adult
24
1984
11351
0.330
Why?
Esophageal Neoplasms
1
2000
75
0.330
Why?
Drug Administration Schedule
10
1984
366
0.300
Why?
Remission Induction
8
1989
161
0.290
Why?
Rectal Neoplasms
3
1985
82
0.280
Why?
Breast Neoplasms
8
1981
673
0.270
Why?
Neoplasm Metastasis
7
1981
228
0.260
Why?
Antineoplastic Agents, Phytogenic
4
1996
40
0.260
Why?
Drug Evaluation
9
1984
101
0.250
Why?
Carboplatin
6
1989
30
0.230
Why?
Pancreatic Neoplasms
1
1994
82
0.220
Why?
Cisplatin
4
1986
95
0.200
Why?
Survival Analysis
5
1994
606
0.200
Why?
Spiro Compounds
3
1988
5
0.190
Why?
Ifosfamide
5
1994
8
0.190
Why?
Fluorouracil
3
1986
78
0.190
Why?
Organometallic Compounds
3
1988
71
0.180
Why?
Aged, 80 and over
5
1996
2529
0.180
Why?
Organoplatinum Compounds
1
1989
6
0.180
Why?
Infusions, Intravenous
4
1987
143
0.180
Why?
Mitoxantrone
4
1984
20
0.170
Why?
Stomach Neoplasms
2
1999
35
0.170
Why?
Male
22
1980
19675
0.170
Why?
Mitomycins
2
1985
17
0.160
Why?
Neoplasm Staging
4
1996
338
0.150
Why?
Carcinoma, Small Cell
2
1983
32
0.150
Why?
Aclarubicin
2
1994
5
0.150
Why?
Folic Acid
1
1987
22
0.150
Why?
Aminoglutethimide
2
1981
6
0.140
Why?
Methotrexate
1
1985
73
0.120
Why?
Neoplasms
3
1992
739
0.120
Why?
Leukopenia
4
1984
24
0.120
Why?
Podophyllotoxin
1
1983
10
0.120
Why?
Allopurinol
2
1987
10
0.110
Why?
Hematologic Diseases
3
1985
39
0.100
Why?
Thrombocytopenia
3
1989
74
0.100
Why?
Budd-Chiari Syndrome
1
1980
9
0.090
Why?
Dacarbazine
1
1980
21
0.090
Why?
Drug-Induced Liver Injury
1
1980
36
0.090
Why?
Nausea
3
1981
155
0.090
Why?
Trimetrexate
1
1999
1
0.090
Why?
Antimetabolites, Antineoplastic
1
1999
40
0.090
Why?
Harringtonines
1
1999
2
0.080
Why?
Hydroxyurea
1
1999
14
0.080
Why?
Interferon-beta
1
1999
63
0.080
Why?
Vomiting
3
1982
115
0.080
Why?
Interleukin-2
1
1999
198
0.080
Why?
Survival Rate
3
1991
618
0.080
Why?
Sarcoma
2
1995
63
0.080
Why?
Colorectal Neoplasms
1
1999
137
0.070
Why?
Pilot Projects
4
1986
442
0.070
Why?
Gout Suppressants
1
1996
7
0.070
Why?
Radiation-Sensitizing Agents
1
1996
75
0.070
Why?
Lymphoma
2
1990
162
0.070
Why?
Uric Acid
1
1996
51
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
42
0.070
Why?
Mitomycin
2
1985
18
0.070
Why?
Carcinoma, Adenoid Cystic
1
1995
10
0.070
Why?
Mesna
1
1994
2
0.060
Why?
Head and Neck Neoplasms
1
1995
83
0.060
Why?
Pelvic Neoplasms
1
1994
15
0.060
Why?
Treatment Outcome
3
1994
2615
0.060
Why?
Chemotherapy, Adjuvant
1
1994
88
0.060
Why?
Vincristine
3
1986
62
0.060
Why?
Adjuvants, Immunologic
1
1994
117
0.060
Why?
Diarrhea
2
1987
66
0.050
Why?
Oncologic Nursing
1
1992
8
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Drug Therapy
1
1992
46
0.050
Why?
Medical Oncology
1
1992
48
0.050
Why?
Behavior Therapy
1
1992
98
0.050
Why?
Melphalan
1
1990
28
0.050
Why?
Multicenter Studies as Topic
1
1990
129
0.040
Why?
Anemia
1
1990
78
0.040
Why?
Random Allocation
1
1989
248
0.040
Why?
Leukemia, Myelomonocytic, Acute
1
1988
11
0.040
Why?
Hydrocortisone
1
1989
131
0.040
Why?
Bone Marrow Transplantation
1
1990
197
0.040
Why?
Catheterization, Central Venous
1
1988
60
0.040
Why?
Stomach
1
1988
72
0.040
Why?
Intestine, Small
1
1988
111
0.040
Why?
Prognosis
1
1989
1083
0.030
Why?
Skin Neoplasms
1
1988
229
0.030
Why?
Injections, Intravenous
2
1990
131
0.030
Why?
Anthraquinones
1
1984
7
0.030
Why?
Liver Neoplasms
1
1986
151
0.030
Why?
Melanoma
2
1980
134
0.030
Why?
Drug Therapy, Combination
2
1989
382
0.030
Why?
Prostatic Neoplasms
1
1989
555
0.030
Why?
Drug Resistance
1
1983
102
0.030
Why?
Sleep Stages
1
1981
20
0.020
Why?
Hormones
1
1981
64
0.020
Why?
Combined Modality Therapy
2
1986
486
0.020
Why?
Mitolactol
2
1989
6
0.020
Why?
Thiotepa
2
1989
8
0.020
Why?
Vinblastine
2
1989
27
0.020
Why?
Necrosis
1
1980
103
0.020
Why?
Dexamethasone
1
1981
181
0.020
Why?
Doxorubicin
2
1989
107
0.020
Why?
Antibiotics, Antineoplastic
1
1999
50
0.020
Why?
Drug Resistance, Neoplasm
1
1999
56
0.020
Why?
Safety
1
1999
101
0.020
Why?
Salvage Therapy
1
1999
59
0.020
Why?
Pain
1
1981
382
0.020
Why?
Ascitic Fluid
1
1996
22
0.020
Why?
Disease Progression
1
1999
521
0.020
Why?
Alopecia
1
1996
21
0.020
Why?
Treatment Failure
1
1996
128
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
1996
44
0.020
Why?
Fever
1
1996
111
0.020
Why?
Liver
1
1980
877
0.020
Why?
Neutropenia
1
1996
67
0.020
Why?
Cohort Studies
1
1999
969
0.020
Why?
Follow-Up Studies
2
1986
1855
0.010
Why?
Kidney
1
1996
586
0.010
Why?
Retrospective Studies
1
1999
2267
0.010
Why?
Time Factors
2
1989
3182
0.010
Why?
Cyclophosphamide
1
1991
174
0.010
Why?
Biological Availability
1
1990
40
0.010
Why?
Carmustine
1
1990
37
0.010
Why?
Fluoxymesterone
1
1989
4
0.010
Why?
Randomized Controlled Trials as Topic
1
1992
411
0.010
Why?
Administration, Oral
1
1990
308
0.010
Why?
Hematoma
1
1988
39
0.010
Why?
Motilin
1
1988
3
0.010
Why?
Periodicity
1
1988
41
0.010
Why?
Nervous System Diseases
1
1989
147
0.010
Why?
Dogs
1
1988
468
0.010
Why?
Palliative Care
1
1989
159
0.010
Why?
Electrophysiology
1
1988
247
0.010
Why?
Behavior, Animal
1
1988
238
0.010
Why?
Animals
1
1988
16093
0.000
Why?

Visualizations


Asbury's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department